Gwen E. Weld - 23 Sep 2022 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Chief People Officer
Signature
/s/ Matthew B. Murphy, as Attorney-in-Fact
Issuer symbol
NAUT
Transactions as of
23 Sep 2022
Net transactions value
+$60,765
Form type
4
Filing time
26 Sep 2022, 21:26:42 UTC
Previous filing
05 May 2022
Next filing
01 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NAUT Common Stock Purchase $60,765 +30,000 $2.03 30,000 23 Sep 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the weighted average share price of an aggregate total of 30,000 shares purchased in the price range of $1.97 to $2.0257 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.